I hold both MDR and PCK. PCK have just been awarded a $5m grant by the government to introduce their app to all 100000 patients who suffer dementia in Australia. This derisked the product, capitalised the company (no threat of a CR) and lent credibility to their big money spinner, detecting pain in babies (at the clinical trial stage).
The app has just been validated in the UK through uptake so it's broader usage around the world has been derisked.
The price jumps have nothing to do with what you can read in the 4C but everything to do with future rollout.
PCK has a far higher operating margin and is heavily geared to sales.
Importantly PCK is now in profit. MDR is not. I'm comfortable with the MC valuations of both companies. However I would not be surprised to see PCK jump to 20c or fall back to 9c. The market is a strange beast.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.01M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35556 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.6¢ | 190000 | 1 |
View Market Depth
| Last trade - 16.21pm 08/08/2025 (20 minute delay) ? |
| MDR (ASX) Chart |
Day chart unavailable